Serving as Chief Medical Officer currently at HepQuant. Biopharma strategic and operational leadership experience over 24 years at both sponsor and CRO leading high performing teams in clinical research, medical affairs and drug safety areas. Expertise in leading early and late phase programs in multiple TAs including transplantation, oncology, immunology and neurology. Late phase programs that have led to approvals in transplantation (CMV, hepatitis B and hepatitis C infections) and Immunology (PID and autoimmune disorders).
Pivoted to investor role and investment advisory, go to market strategies. Mentoring multiple start-ups and founders including Entrepreneur-in-Residence UMassM2D2, Midwest Pediatric Device Consortium (MPDC) Clinical Advisory Council.
Rare disease advisory board member Center for Innovation and Value Research. Previously served as Board of Director at BioFlorida.
Executive education at MIT Sloan School of Management focused on management and leadership. Venture Capital Fellowship at Material Change Institute.
Graduated with medical degree from Seth GS Medical School in Mumbai, India.
I chose to serve on The Beautiful Way Foundation’s Advisory Board because of my focus on bringing change in terms of identifying barriers, improving access, and enhancing education to reduce bias using data.
- Current Events
- Upcoming Events
- Past Events